what percentage of money given to leukemia/lymphomagoes to administration

April 07, 2022 Post a Comment

LLS FY 19 Financial Allocation

Throughout our 70-twelvemonth history, The Leukemia & Lymphoma Gild has existed to detect cures for claret cancers and provide support for patients and families.

Each year, we raise significant funds to invest in cut-edge enquiry and world-class patient education and support programs, which are free of charge to patients. This lifesaving work can exist done only with the support of generous individual donors, companies and foundations who trust LLS to invest donated funds wisely, responsibly and for the greatest impact for cancer patients and families.

Each twelvemonth we assess and address the most critical patient needs and balance our investment in patient-focused services and ground-breaking inquiry, to achieve the best effect for patients. Our guiding principal is a steadfast delivery to helping patients and families dealing with a blood cancer diagnosis and treatment.

How did we raise money in FY2019?
Donations were derived from four main sources:

Peer-to-peer fundraising
Corporate back up
Individual gifts and
In-kind contributions.

In full, LLS received $414.3 one thousand thousand from donors to back up our mission and operations. These donations, making LLS the 2nd largest cancer-focused voluntary health organization in the world, allow the states to work at meaning scale, and in the best involvement of patients.

How did we spend those precious dollars?
In financial year 2019, we spent $284 million or 73% of our expenses on specific programs designed to find new treatments for blood cancers and to serve blood cancer patients. To brand these programs possible, we spent a total of $103 million or 27% of our expenses on operations and fundraising. The chart below provides a graphic representation of these expenses.

Just permit u.s.a. give you a deeper appreciation of how these dollars were invested or spent:

Research:
$71 million or 18% of our expenditures was invested in cutting-edge research at major medical centers and biotechnology companies. This adds to the $ane.3 billion investment LLS has made in research since our founding, which volition proceed to drive the adjacent generation of therapies for claret cancer patients.

Services for Patients:
$153 million or 39% of our expenditures were invested in services to claret cancer patients. These services include social and emotional support through counselling from oncology nurses and social workers, dietary counselling provided by a registered dietitian, navigation to clinical trials, referrals for second opinions and fiscal aid for transportation, insurance and co-pay, and emergency expenses.

Public Health Education:
$45 1000000 or 12% of our expenditures were made to brainwash patients and their families virtually the blood cancers. Education was offered, free of charge, to patients at x Blood Cancer Conferences held in major cities around the U.S. We educated more than 132,400 patients, caregivers, healthcare professionals and others through alive web-based and local in-person programs that featured blood cancer experts describing the latest treatment options and answering participant questions. Blog posts and web-based educational activity materials were supplemented with printed educational material for all of the blood cancers published in, at to the lowest degree, English and Castilian. Nosotros distributed more than 855,000 educational booklets and fact sheets most blood cancers and survivorship topics terminal year alone to patients, caregivers and medical centers.

Professional person Education:
$14.5 one thousand thousand or 4% of our expenditures were invested in educating healthcare professionals (physicians, oncology nurses, social workers and pharmacists) nearly the blood cancers to be sure they take the near up-to-appointment noesis about these rare diseases and are best equipped to assist patients.

Fundraising:
$48 million or 13% of our expenditures supported LLS fundraising efforts. These dollars fueled our fundraising campaigns and the marketing that we do to solicit funds. With donations in FY19 totaling $414 million, this means information technology cost LLS merely xiii cents to raise each dollar.

Business Operations:
$54 1000000 or xiv% of our expenditures were spent for business operations that make delivering our mission programs possible. These dollars supported IT infrastructure, our local offices across the U.S. and Canada that deliver patient services to the local community, and our national office that houses our research and patient back up teams, along with shared service teams like Finance and Accounting, Human Resources and Communications. This investment allows us to appoint straight with patients, caregivers, researchers and donors.

How does this compare with terminal year?
In FY2019 we spent a higher percentage on business organisation operations because we made a significant investment to improve our It infrastructure. We moved software and data into the cloud and provided laptops to staff in chapters beyond the country to enhance productivity. As fate would have information technology, in the era of COVID-19, this was a wise investment that has allowed LLS to proceed to deliver and fund its mission, even as staff sheltered-in-place and work from abode. Y'all can meet the year-to-year comparing illustrated beneath.

We hope this helps you to understand meliorate our impact every bit an arrangement.
Should you have farther questions, please accomplish out to Andrea Greif, VP Communications, at andrea.greif@lls.org.